ZA924902B - Medicament against cancer or aids - Google Patents

Medicament against cancer or aids

Info

Publication number
ZA924902B
ZA924902B ZA924902A ZA924902A ZA924902B ZA 924902 B ZA924902 B ZA 924902B ZA 924902 A ZA924902 A ZA 924902A ZA 924902 A ZA924902 A ZA 924902A ZA 924902 B ZA924902 B ZA 924902B
Authority
ZA
South Africa
Prior art keywords
aids
against cancer
medicament against
adenine dinucleotide
nicotinamide adenine
Prior art date
Application number
ZA924902A
Inventor
Jorg Birkmayer
Birkmayer Jorg
Original Assignee
Birkmayer Joerg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Birkmayer Joerg filed Critical Birkmayer Joerg
Publication of ZA924902B publication Critical patent/ZA924902B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Use of nicotinamide adenine dinucleotide (NADH), nicotinamide adenine dinucleotide phosphate (NADPH) or of a physiologically tolerated salt thereof for the treatment of cancer or AIDS.
ZA924902A 1991-08-26 1992-07-01 Medicament against cancer or aids ZA924902B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4128625A DE4128625A1 (en) 1991-08-26 1991-08-26 MEDICINE AGAINST CANCER AND AIDS

Publications (1)

Publication Number Publication Date
ZA924902B true ZA924902B (en) 1993-04-28

Family

ID=6439356

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA924902A ZA924902B (en) 1991-08-26 1992-07-01 Medicament against cancer or aids

Country Status (13)

Country Link
EP (1) EP0534097B1 (en)
JP (1) JP3493202B2 (en)
AT (1) ATE150313T1 (en)
AU (1) AU653619B2 (en)
BR (1) BR9203302A (en)
CA (1) CA2072484C (en)
DE (2) DE4128625A1 (en)
DK (1) DK0534097T3 (en)
ES (1) ES2099772T3 (en)
GR (1) GR3023191T3 (en)
HU (1) HUT61895A (en)
NO (1) NO300915B1 (en)
ZA (1) ZA924902B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2302687A1 (en) * 1997-09-11 1999-03-18 Oxigene, Inc. Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
US20040126751A1 (en) * 2002-12-27 2004-07-01 Birkmayer Jorg G.D. Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1162938B (en) * 1983-08-26 1987-04-01 Dino Spisni COMPOSITION FOR THE TREATMENT OF MALIGNANT CANCERS, IN PARTICULAR ON ANIMALS
CA1336169C (en) * 1988-03-01 1995-07-04 Walther Birkmayer Agent for treatment of parkinson's disease

Also Published As

Publication number Publication date
NO923324L (en) 1993-03-01
EP0534097A2 (en) 1993-03-31
EP0534097A3 (en) 1993-07-14
DE4128625A1 (en) 1993-04-08
GR3023191T3 (en) 1997-07-30
DK0534097T3 (en) 1997-09-22
NO300915B1 (en) 1997-08-18
DE4128625C2 (en) 1993-08-12
AU2125392A (en) 1993-03-04
CA2072484A1 (en) 1993-02-27
JP3493202B2 (en) 2004-02-03
EP0534097B1 (en) 1997-03-19
BR9203302A (en) 1993-03-30
HUT61895A (en) 1993-03-29
NO923324D0 (en) 1992-08-25
AU653619B2 (en) 1994-10-06
DE59208223D1 (en) 1997-04-24
JPH072678A (en) 1995-01-06
ATE150313T1 (en) 1997-04-15
ES2099772T3 (en) 1997-06-01
CA2072484C (en) 2002-02-26

Similar Documents

Publication Publication Date Title
ES2051641A1 (en) Compounds and methods for inhibition of HIV and related viruses.
HU9302496D0 (en) Method for producing anti-viral nucleoside combinations and one for preparing medical preparatives containing said compounds
TW231268B (en)
CA2078670A1 (en) Compositions and methods for treatment of acne vulgaris and retardation of ageing
WO1999012951A8 (en) Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
ZA924902B (en) Medicament against cancer or aids
AU9010991A (en) Antidepressant
AU7719491A (en) Therapeutic compound
MY103748A (en) A new antitumor agent obtained by microbial stereoselective reduction of 4-deoxy-4-iododoxorubicin